Market Overview:
The global diabetes management devices market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of diabetes, technological advancements in diabetes management devices, and rising awareness about diabetes. The blood glucose monitoring device segment is expected to dominate the global diabetes management devices market during the forecast period. This segment is expected to grow at a CAGR of 8% during the forecast period from 2018 to 2030. The insulin delivery systems segment is also projected to grow at a high rate during the forecast period owing to technological advancements and rising demand for insulin delivery systems globally.
Product Definition:
Diabetes management devices are gadgets that help people manage their diabetes. This might include tools to measure blood sugar levels, insulin pumps, or other devices meant to help people stay on top of their diabetes. These devices can be extremely important for managing the disease, as they can help people keep track of their blood sugar levels and make sure they are taking the right medications and doses.
Blood glucose monitoring device:
Blood glucose monitoring (BGM) devices are used to measure the blood sugar level of patient with diabetes mellitus. The BGM device is an important tool in diabetes management as it helps in maintaining a normal blood glucose level and avoiding frequent high and low sugar levels. Blood glucose monitoring devices market is segmented on the basis of product type such as self-monitoring, continuous, bedside, and handheld devices.
Insulin delivery systems:
Insulin delivery systems and it's usage in diabetes management devices market is expected to witness significant growth over the forecast period. Insulin delivery system refers to the technology used for transporting insulin into a patient’s body. There are two types of insulin delivery systems, namely, pen-based and injection-based.
Application Insights:
In 2017, the hospitals segment dominated the diabetes management devices market and this trend is expected to continue over the forecast period. This can be attributed to a large patient base with diabetes and rising prevalence of DMDs. Furthermore, increasing number of research studies are being conducted in order to improve care for patients suffering from diabetes at hospitals. For instance, according to an article published by NCBI in 2018, it was found that out of all hospital-based diabetic clinics; only 20% provide integrated care through a multidisciplinary team led by endocrinologists or diabetologists along with other specialists such as dietitians and pharmacists. Thus there is a huge unmet need for these services at hospitals across countries which will eventually drive growth over next few years.
The clinics & laboratories segment accounted for revenue share of 22% in 2017 owing to growing demand for self-monitoring devices among patients suffering from Diabetes Mellitus (DM).
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to increasing prevalence of diabetes and rising awareness about advanced products. Asia Pacific is estimated to be the fastest-growing regional market from 2018 to 2030 owing to improving healthcare infrastructure, growing patient pool, and increasing demand for cost-effective devices. Moreover, a large number of diabetic patients are living with undiagnosed or untreated conditions that further increase their risk of developing complications over a long period of time thus leading them into severe financial crisis as well as health issues such as blindness, kidney failure, etc.
Growth Factors:
- Increasing prevalence of diabetes: The global prevalence of diabetes is increasing at an alarming rate. This is primarily due to the changing lifestyle and dietary habits of people across the world. According to a study by the International Diabetes Federation, there were 415 million people with diabetes in 2015, and this number is expected to reach 642 million by 2030. This will create a large pool of patients who will require treatment for their condition, thereby providing a major growth driver for the diabetes management devices market.
- Rising awareness about diabetes: There has been a significant increase in awareness about diabetes in recent years, owing to campaigns by various healthcare organizations and governments around the world. As a result, more people are now aware of the risks associated with uncontrolled blood sugar levels and are seeking appropriate treatment for their condition. This is likely to drive demand for diabetic management devices in coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Diabetes Management Devices Market Research Report
By Type
Blood glucose monitoring device, Insulin delivery systems
By Application
Hospitals, Clinics and laboratories, Others
By Companies
Abbott, Dexcom, F. Hoffmann-La Roche, LifeScan, Medtronic, AgaMatrix, Animas, ARKRAY, Ascensia Diabetes Care, B. Braun Melsungen, BD, Beta Bionics, Bigfoot Biomedical, BIONIME USA, CellNovo, Eli Lilly, iHealth Labs, Insulet, Nemaura Medical, Nipro, Nova Biomedical, Novo Nordisk, Panasonic Healthcare, Prodigy Diabetes Care, Sanofi, Senseonics, Tandem Diabetes Care, Trividia Health, TypeZero Technologies, Valeritas, WellDoc
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
249
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Diabetes Management Devices Market Report Segments:
The global Diabetes Management Devices market is segmented on the basis of:
Types
Blood glucose monitoring device, Insulin delivery systems
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics and laboratories, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- Dexcom
- F. Hoffmann-La Roche
- LifeScan
- Medtronic
- AgaMatrix
- Animas
- ARKRAY
- Ascensia Diabetes Care
- B. Braun Melsungen
- BD
- Beta Bionics
- Bigfoot Biomedical
- BIONIME USA
- CellNovo
- Eli Lilly
- iHealth Labs
- Insulet
- Nemaura Medical
- Nipro
- Nova Biomedical
- Novo Nordisk
- Panasonic Healthcare
- Prodigy Diabetes Care
- Sanofi
- Senseonics
- Tandem Diabetes Care
- Trividia Health
- TypeZero Technologies
- Valeritas
- WellDoc
Highlights of The Diabetes Management Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Blood glucose monitoring device
- Insulin delivery systems
- By Application:
- Hospitals
- Clinics and laboratories
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Diabetes Management Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Diabetes management devices are medical devices that help people with diabetes control their blood sugar levels. These devices can include insulin pumps, glucose monitors, and other treatments.
Some of the major players in the diabetes management devices market are Abbott, Dexcom, F. Hoffmann-La Roche, LifeScan, Medtronic, AgaMatrix, Animas, ARKRAY, Ascensia Diabetes Care, B. Braun Melsungen, BD, Beta Bionics, Bigfoot Biomedical, BIONIME USA, CellNovo, Eli Lilly, iHealth Labs, Insulet, Nemaura Medical, Nipro, Nova Biomedical, Novo Nordisk, Panasonic Healthcare, Prodigy Diabetes Care, Sanofi, Senseonics, Tandem Diabetes Care, Trividia Health, TypeZero Technologies, Valeritas, WellDoc.
The diabetes management devices market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Diabetes Management Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Diabetes Management Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Diabetes Management Devices Market - Supply Chain
4.5. Global Diabetes Management Devices Market Forecast
4.5.1. Diabetes Management Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Diabetes Management Devices Market Size (000 Units) and Y-o-Y Growth
4.5.3. Diabetes Management Devices Market Absolute $ Opportunity
5. Global Diabetes Management Devices Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Diabetes Management Devices Market Size and Volume Forecast by Type
5.3.1. Blood glucose monitoring device
5.3.2. Insulin delivery systems
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Diabetes Management Devices Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Diabetes Management Devices Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Clinics and laboratories
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Diabetes Management Devices Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Diabetes Management Devices Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Diabetes Management Devices Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Diabetes Management Devices Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Diabetes Management Devices Demand Share Forecast, 2019-2026
9. North America Diabetes Management Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Diabetes Management Devices Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Diabetes Management Devices Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Clinics and laboratories
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Diabetes Management Devices Market Size and Volume Forecast by Type
9.7.1. Blood glucose monitoring device
9.7.2. Insulin delivery systems
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Diabetes Management Devices Demand Share Forecast, 2019-2026
10. Latin America Diabetes Management Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Diabetes Management Devices Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Diabetes Management Devices Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Clinics and laboratories
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Diabetes Management Devices Market Size and Volume Forecast by Type
10.7.1. Blood glucose monitoring device
10.7.2. Insulin delivery systems
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Diabetes Management Devices Demand Share Forecast, 2019-2026
11. Europe Diabetes Management Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Diabetes Management Devices Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Diabetes Management Devices Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Clinics and laboratories
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Diabetes Management Devices Market Size and Volume Forecast by Type
11.7.1. Blood glucose monitoring device
11.7.2. Insulin delivery systems
11.8. Bsis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Diabetes Management Devices Demand Share, 2019-2026
12. Asia Pacific Diabetes Management Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Diabetes Management Devices Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Diabetes Management Devices Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Clinics and laboratories
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Diabetes Management Devices Market Size and Volume Forecast by Type
12.7.1. Blood glucose monitoring device
12.7.2. Insulin delivery systems
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Diabetes Management Devices Demand Share, 2019-2026
13. Middle East & Africa Diabetes Management Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Diabetes Management Devices Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Diabetes Management Devices Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Clinics and laboratories
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Diabetes Management Devices Market Size and Volume Forecast by Type
13.7.1. Blood glucose monitoring device
13.7.2. Insulin delivery systems
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Diabetes Management Devices Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Diabetes Management Devices Market: Market Share Analysis
14.2. Diabetes Management Devices Distributors and Customers
14.3. Diabetes Management Devices Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Abbott
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Dexcom
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. F. Hoffmann-La Roche
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. LifeScan
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Medtronic
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. AgaMatrix
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Animas
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. ARKRAY
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Ascensia Diabetes Care
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. B. Braun Melsungen
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. BD
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Beta Bionics
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Bigfoot Biomedical
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. BIONIME USA
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. CellNovo
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Eli Lilly
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. iHealth Labs
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. Insulet
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. Nemaura Medical
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. Nipro
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
